TKI has been reported as a successful neoadjuvant for total thyroidectomy to reduce tumor burden [13] and enhance RAI sensitivity of thyroid cancer including an increased sodium/iodide symporter expression [14]. The gene discussed is SLC5A5; the disease is thyroid gland carcinoma.